World Aug 17 News Wrap: Military response to North Korea still an option, says Tillerson By PBS News Hour
Health Jun 01 Mylan may have overcharged taxpayers by $1.27 billion for EpiPens, HHS says Mylan may have overcharged taxpayers as much as $1.27 billion over 10 years for its signature EpiPens, according to an analysis released Wednesday. By Ike Swetlitz, STAT
Health Sep 21 Mylan CEO defends EpiPen cost to angry lawmakers The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. By Mary Clare Jalonick, Associated Press
Politics Sep 02 Clinton offers plan to prevent ‘excessive’ drug price hikes Following the public outcry over steep increases in price for an emergency allergy treatment, Hillary Clinton is pledging to better protect patients from such costs. By Catherine Lucey, Associated Press
Health Aug 29 Watch 7:41 Did outcry on social media lead to Mylan’s generic EpiPen? After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New… By PBS News Hour
Aug 29 EpiPen drugmaker announces generic version to cost half the price By News Desk Identical to the original product -- a pre-filled syringe containing epinephrine, used for life-threatening allergic reactions -- the generic will cost $300 for two. Continue reading
Aug 26 Mylan may have violated antitrust law in its EpiPen sales to schools By Ike Swetlitz and Ed Silverman, STAT Mylan’s “EpiPen4Schools” program, begun in August 2012, offers free or discounted EpiPens to schools. Continue reading